Home › Triple-Negative Breast Cancer › Texas › Abilene
Triple-Negative Breast Cancer clinical trials in Abilene, TX
3 studies for Triple-Negative Breast Cancer are looking for participants at sites in and around Abilene (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RecruitingPhase 3
- Hendrick Medical Center ( Site 0009), Abilene
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
RecruitingPhase 3
- Hendrick Medical Center ( Site 0117), Abilene
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecruitingPhase 1/2
- USOR Texas Oncology, Abilene
Triple-Negative Breast Cancer trials in other cities
- Houston, TX42 studies
- New York City, NY31 studies
- Nashville, TN28 studies
- Los Angeles, CA27 studies
- Boston, MA26 studies
- San Antonio, TX23 studies
- St. Louis, MO21 studies
- Atlanta, GA20 studies
- Arlington, VA20 studies
- Dallas, TX18 studies
- Chicago, IL16 studies
- Columbus, OH16 studies
Other studies in Abilene
- Non-Small Cell Lung Cancer8 studies
- Breast Cancer5 studies
- Metastatic Cancer5 studies
- Colorectal Cancer5 studies
- Ovarian Cancer4 studies
- Macular Degeneration4 studies
- Geographic Atrophy3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.